The Difference Between Quitting Nicotine and Ending Smoking

Every so often, a paper appears that calls for a “balanced perspective.” It is a phrase that sounds reassuring because science should be balanced, public policy should be balanced, and decisions that affect millions of lives should certainly be balanced. But balance is not achieved simply by saying the word. It is achieved by giving competing ideas fair consideration, weighing the evidence objectively, and being prepared to change course when new evidence emerges.

That is why I found the recent Addiction commentary, “The Need for a Balanced Perspective on Tobacco Cessation and Taxation,” so interesting. The paper argues for continuing traditional tobacco control measures such as smoking cessation support and tobacco taxation. These approaches have long formed the foundation of tobacco control policy and may have contributed to reductions in smoking in many countries. However, treating them as the primary solution today overlooks how dramatically the nicotine landscape has changed over the past decade.

One of the most significant developments in modern tobacco control has been the emergence of non-combustible nicotine products. Millions of smokers around the world have switched from cigarettes to vaping products, heated tobacco products, nicotine pouches and snus, and countries that have adopted more proportionate regulation of these products have often experienced rapid declines in smoking. This is not a peripheral issue or a passing trend. It represents one of the most important changes in tobacco control since the health risks of smoking first became widely understood. Yet discussions about “balance” continue to focus predominantly on traditional strategies while giving comparatively little attention to harm reduction.

The contrast with another recent paper by Ron Borland and colleagues could hardly be greater. Rather than asking how existing policies can be reinforced, they ask whether Australia’s tobacco and nicotine policies are still achieving their intended outcomes. Their conclusion is refreshingly candid. Australia has largely lost control of both its tobacco and nicotine markets, illicit supply has become widespread, enforcement alone is unlikely to restore control, and the current regulatory settings require serious reconsideration. That is not an ideological position. It is an acknowledgement that policies should ultimately be judged by what they achieve rather than what they were designed to achieve.

There is an important philosophical difference between these two approaches. One begins by assuming that established tobacco control strategies remain the answer and asks how they can be maintained. The other begins by examining today’s reality and asks whether those strategies are still fit for purpose. Those are very different starting points, and they naturally lead to different conclusions.

The difference becomes even clearer when we consider the question each approach is really trying to answer. Traditional tobacco control often asks, “How do we get people to quit nicotine?” Harm reduction asks something different: “How do we get as many people as possible away from combustible cigarettes?” Those are not the same question, and the distinction matters enormously.

If nicotine itself is treated as the primary problem, then every nicotine product becomes an obstacle. If combustion is recognised as the primary source of smoking-related disease, however, the policy objective changes dramatically. The question becomes how to move smokers as quickly and safely as possible towards products that substantially reduce their exposure to toxic combustion. That single shift in thinking changes almost everything. It changes how products are regulated, how they are taxed, how risks are communicated and, ultimately, how success is measured.

For decades, tobacco control operated in a world where cigarettes dominated the nicotine market and few practical alternatives existed. Today that world no longer exists. Smokers who have struggled to quit now have access to products that can substantially reduce their exposure to the toxic chemicals produced by combustion. Ignoring those alternatives does not make them disappear; it simply creates a widening gap between public policy and the choices millions of consumers are already making.

There is another reason this debate matters. Science is not supposed to defend established positions; it is supposed to test them. Every major advance in public health has come from questioning assumptions, re-examining evidence and being willing to revise recommendations when the facts change. A policy that was appropriate twenty years ago is not automatically the best policy today if the environment, technology and available evidence have fundamentally changed. Tobacco harm reduction should be evaluated in exactly the same way—not by asking whether it fits comfortably within existing doctrine, but by asking whether it reduces disease and death more effectively than the alternatives available to smokers today.

This does not mean claiming that every alternative nicotine product is harmless, abandoning youth protections or giving industry a free pass. It simply means asking the same question that good science has always asked: Compared with what? Compared with continued smoking, does switching reduce harm? Compared with maintaining cigarette use, does it improve health outcomes? Compared with prohibition, does regulated access produce better public health outcomes? Those are the comparisons that matter because they reflect the choices smokers actually face.

Real balance requires acknowledging both benefits and risks. It requires recognising that nicotine dependence is not the same thing as smoking-related disease, accepting that some people will never achieve complete nicotine abstinence but can successfully leave combustible cigarettes behind, and measuring success by reductions in disease and death rather than simply reductions in nicotine use.

Perhaps most importantly, it requires humility. Public health has never advanced by assuming yesterday’s policies will automatically solve tomorrow’s problems. It advances by learning, adapting and responding to new evidence. The irony is that almost everyone involved in tobacco control ultimately shares the same objective: fewer people smoking, less disease and fewer deaths. The disagreement is not about the destination but about the most effective path to get there.

If we genuinely want a balanced perspective, then we cannot continue treating safer nicotine alternatives as an uncomfortable side issue while discussing the future of tobacco control. They are already part of that future. The real question is whether public policy is prepared to catch up with the evidence.